Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Mistletoe therapy from the pharmacologic perspective].

T Hajto1, K Hostanska, R Saller

  • 1Abteilung Naturheilkunde, Departement Innere Medizin, Universitätsspital Zürich, Schweiz.

Forschende Komplementarmedizin
|October 26, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of Lipophilic Extract of Viscum album L. and Oleanolic Acid on Migratory Activity of NIH/3T3 Fibroblasts and on HaCat Keratinocytes.

Evidence-based complementary and alternative medicine : eCAM·2014
Same author

[Multimorbidity and multi-target-therapy with herbal drugs].

Praxis·2012
Same author

Investigations of cellular parameters to establish the response of a biomodulator: galactoside-specific Lectin from Viscum album plant extract.

Phytomedicine : international journal of phytotherapy and phytopharmacology·2012
Same author

Reduction of behavioural disturbances in elderly dogs supplemented with a standardised Ginkgo leaf extract.

Schweizer Archiv fur Tierheilkunde·2006
Same author

Peritoneal cancer treatment with CYP2B1 transfected, microencapsulated cells and ifosfamide.

Cancer gene therapy·2005
Same author

A novel colorimetric broth microdilution method to determine the minimum inhibitory concentration (MIC) of antibiotics and essential oils against Helicobacter pylori.

Die Pharmazie·2005

Viscum album agglutinin (VAA)-I, a mistletoe lectin, induces apoptosis in cancer cells and modulates the immune system. It stimulates natural killer (NK) cells and enhances immune responses, suggesting potential in cancer therapy.

Area of Science:

  • Immunology
  • Molecular Biology
  • Oncology

Context:

  • Mistletoe extracts are used in cancer therapy for their cytostatic and immunomodulatory effects.
  • Viscum album agglutinin (VAA)-I and -II are key components of mistletoe extracts, belonging to type-II ribosome-inactivating proteins.
  • VAA-I exhibits in vitro cytostatic effects on various eukaryotic cells.

Purpose:

  • To investigate the dose-dependent effects of VAA-I on apoptosis in human peripheral lymphocytes.
  • To evaluate VAA-I's impact on cytokine expression and immune cell stimulation in peripheral blood mononuclear cells (PBMC).
  • To explore VAA-I's potential as an immunomodulator for cancer patients with compromised natural immunity.

Summary:

  • VAA-I induced dose-dependent apoptosis in human lymphocytes and stimulated proinflammatory cytokine mRNA expression and secretion in PBMC at non-cytotoxic concentrations.

Related Experiment Videos

  • VAA-I enhanced NK cell stimulation, additively with IL-2 and IL-12, and promoted clonogenic growth of hematopoietic cells.
  • Studies in animal models and humans suggest VAA-I can sustain elevated NK cell numbers and activity, with optimal doses identified for immune modulation.

    • Impact:

    • VAA-I demonstrates selective apoptotic effects, offering a novel approach to manipulating the balance between cell growth and programmed cell death.
    • The combination of VAA-I's immunomodulatory and cytotoxic properties presents new clinical perspectives for mistletoe therapy in cancer patients.
    • VAA-I acts as a potent modulator of the natural immune system, potentially improving therapeutic outcomes in oncology.